These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9499825)

  • 21. [Meningitis caused by Listeria monocytogenes in the patient with multiple myeloma].
    Pokrovskaia OS; Mendeleeva LP; Gribanova EO; Ustinova EN; Kliasova GA; Sharikova OA; Galstian GM; Iatskov KV; Varlamova EIu; Kaplanskaia IB
    Ter Arkh; 2003; 75(7):76-8. PubMed ID: 12934487
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapy-related infections in patients with multiple myeloma: associations with mannan-binding lectin genotypes.
    Mølle I; Steffensen R; Thiel S; Peterslund NA
    Eur J Haematol; 2006 Jul; 77(1):19-26. PubMed ID: 16827883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for the development of bacterial infections in multiple myeloma treated with two different vincristine-adriamycin-dexamethasone schedules.
    Cesana C; Nosari AM; Klersy C; Miqueleiz S; Rossi V; Ferrando P; Valentini M; Barbarano L; Morra E
    Haematologica; 2003 Sep; 88(9):1022-8. PubMed ID: 12969810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple complications in multiple myeloma.
    Basi S; Schulman G; Fogo AB
    Am J Kidney Dis; 2005 Mar; 45(3):619-23. PubMed ID: 15754288
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment options and considerations for the newly diagnosed myeloma patient.
    Rajkumar VS;
    Oncology (Williston Park); 2005 Sep; 19(10):1260, 1262, 1267 passim. PubMed ID: 16285223
    [No Abstract]   [Full Text] [Related]  

  • 26. Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma.
    Hequet O; Dumontet C; El Jaafari-Corbin A; Salles G; Espinouse D; Arnaud P; Thieblemont C; Bouafia F; Coiffier B
    Bone Marrow Transplant; 2002 Mar; 29(6):544. PubMed ID: 11960281
    [No Abstract]   [Full Text] [Related]  

  • 27. Thalidomide-dexamethasone as primary therapy for advanced multiple myeloma.
    Wang M; Weber DM; Delasalle K; Alexanian R
    Am J Hematol; 2005 Jul; 79(3):194-7. PubMed ID: 15981221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.
    Huston A; Brown J; Roodman GD
    Exp Hematol; 2006 Dec; 34(12):1616. PubMed ID: 17157156
    [No Abstract]   [Full Text] [Related]  

  • 29. [Improved prognosis of generalized AL-amyloidosis in a patient with multiple myeloma treated according to the VAD protocol].
    Sarkisova IA; Rameev VV; Kozlovskaia LV; Andreeva NE
    Ter Arkh; 2003; 75(8):81-2. PubMed ID: 14520860
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapy-resistant leg ulcer caused by multiple myeloma.
    Bago A; Schweiter J; Kiss M; Furesz J; Vajda A; Balo-Banga JM
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):647-8. PubMed ID: 16164734
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.
    Witzens-Harig M; Waldherr R; Beimler J; Zeier M; Hansmann J; Ho AD; Goldschmidt H; Moehler T
    Ann Hematol; 2007 Dec; 86(12):927-30. PubMed ID: 17605010
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of high-dose melphalan with a more intensive regimen of thiotepa, busulfan, and cyclophosphamide for patients with multiple myeloma.
    Anagnostopoulos A; Aleman A; Ayers G; Donato M; Champlin R; Weber D; Alexanian R; Giralt S
    Cancer; 2004 Jun; 100(12):2607-12. PubMed ID: 15197803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Rapid growth of glioblastoma during therapy for multiple myeloma: case report].
    Sonoda Y; Kumabe T; Umezawa K; Shimizu H; Murakawa Y; Kanamaru R; Yoshimoto T
    No Shinkei Geka; 1998 Aug; 26(8):737-41. PubMed ID: 9744004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous metastatic plasmacytomas with tropism for a previously injured limb.
    Pereira MA; Baudrier T; Costa A; Magalhães J; Azevedo F
    Dermatol Online J; 2008 Sep; 14(9):16. PubMed ID: 19061598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Vanishing" spinal cord compression in myeloma: dramatic and rapid response to dexamethasone monotherapy.
    Azad A; Tafreshi A; Liew MS; Yap LP
    Spine J; 2013 May; 13(5):588-9. PubMed ID: 23498928
    [No Abstract]   [Full Text] [Related]  

  • 36. Satisfactory remission in a case of IgD myeloma: effectiveness of glucocorticoid treatment.
    Takemori N; Kondo K; Kawamura T; Imai K; Sakurai H; Sato T
    Am J Hematol; 2001 Jan; 66(1):62-3. PubMed ID: 11426497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tandem autologous stem cell transplantation for multiple myeloma: is it applicable and effective outside clinical trials?
    Dimopoulos MA
    Haematologica; 2005 Dec; 90(12):1588. PubMed ID: 16330425
    [No Abstract]   [Full Text] [Related]  

  • 38. Bortezomib-dexamethasone combination in a patient with refractory multiple myeloma and impaired renal function.
    Nozza A; Siracusano L; Armando S
    Clin Ther; 2006 Jun; 28(6):953-9. PubMed ID: 16860177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extradural spinal myeloma and emergency neurosurgery.
    Jacobs P; King HS; Le Roux I; Handler L; de Villiers JC
    S Afr Med J; 1990 Mar; 77(6):316-8. PubMed ID: 2340025
    [No Abstract]   [Full Text] [Related]  

  • 40. Combination of pamidronate and thalidomide in the therapy of treatment-resistant multiple myeloma.
    Ciepłuch H; Baran W; Hellmann A
    Med Sci Monit; 2002 Apr; 8(4):PI31-6. PubMed ID: 11951079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.